FCPM III Services B.V.

FCPM III Services B.V. is a private investment firm based in Naarden, Netherlands, specializing in healthcare and biotechnology investments. The firm operates as part of Forbion, a prominent European venture capital firm, focusing on private equity and venture capital investments in the life sciences sector. FCPM III Services B.V. manages assets invested primarily in biotech and pharmaceutical ventures, targeting innovative healthcare solutions globally. The firm typically serves institutional investors, pooling capital into high-growth potential therapeutics and medical technology companies.

Through its affiliation with Forbion, FCPM III Services B.V. employs a venture capital investment strategy centered on innovative biotechnology and pharmaceutical companies. The fund invests in both early and growth-stage companies developing transformative healthcare solutions, emphasizing rigorous scientific due diligence and a hands-on approach to company building. Portfolio construction focuses on diversified exposure within the life sciences sector, seeking long-term value creation through partnerships with entrepreneurs and strategic exits via public markets or mergers and acquisitions.

FCPM III Services B.V. has a track record of active investments in the healthcare and biotechnology sectors. As of June 30, 2025, the firm reported holdings valued at approximately $369 million, with a portfolio comprising eight companies. Notable investments include NewAmsterdam Pharma Company, Dynavax Technologies Corporation, Replimune Group Inc., and Engene Holdings Inc. The firm's investment philosophy emphasizes supporting innovative companies that address unmet medical needs, aiming to drive advancements in healthcare through strategic partnerships and active involvement in portfolio companies' growth and development.